Markets March On But Caution Could Be Key

by Brooks Wealth on February 5, 2011

As I pointed out last week, I am personally in a cautious mood with regards the markets right now. Despite this caution and despite an early week hit to the markets on the crises in Egypt, the Dow still managed to break through 12,000. I am more comfortable with the larger cap value stocks here than their smaller counterparts but whilst markets may appear overbought on my daily and technical indicators, there is no restriction on the length of time these markets may stay in overbought condition. Therefore, don’t be over surprised if the market continues it’s movement forward but it is vital in these situations to remain vigilant if you are considering participating. Always look to the quality and valuation amongst other things when looking to invest.

Whilst the media might be rejoicing at the economic recovery in the US right now, lets call a spade a spade. The recovery is due to the quantitative easing measures of the Fed and low interest rates. We are yet to see if this recovery is sustainable without such stimulus and it is quite clear that the stubborn unemployment rate doesn’t look like decreasing dramatically any time soon. For this reason, and due to the relatively higher than average P/E ratios of the US indexes, I believe a correction is overdue (but not a complete collapse). The economy is recovering but it is going to take a long, long time and the markets certainly seem to have gotten ahead of themselves.

As for the portfolio, we had a few earnings results and despite my caution, I actually entered into an options position with a short term view. Long term value investors might night like the thought of this short term “trading” but I comfortable with this and have to admit, I think there is role for technical analysis to play in value investing. Legends such as Buffett, Graham, Lynch and more might have me hung for such a statement though! Despite this short term view, the basic fundamental analysis comes back to the same question……Is the company trading at a cheap price? I believe so.

Earnings

Raytheon

The group delivered slightly weaker than expected Revenue of $6.9bln but Operating Margin was resilient at 11.7% due to strong cost controls and volume increases in certain segments. Reported earnings per share, adjusted for pension expenses, were $1.37 while the company generated strong operating cash flow of $861 million, bringing the yearly total to $1.9 billion. Raytheon continues to take advantage of what they believe is a currently undervalued share price (as I too believe), by using $1.45 billion to repurchase 28.9 billion shares during 2010, a figure which represents 7% of shares outstanding.

As for 2011, Raytheon forecasts revenue of $25.5-$26.3 billion, compared to the average analyst expectation of $26.2 billion. Meanwhile, EPS is forecast to be $4.83-$4.98, which compares to the average analyst call of $4.88. The tax rate is expected to increase to approximately 30.5% but the shares outstanding should decline to 353-359 million form the current figure of 377 million.
I am currently updating my numbers to determine if my fair value estimate needs to be adjusted but from reading through the earnings transcript, I doubt there is anything here that is going to move the needle too much. I continue to be impressed by the cash flow generating ability of the business and should EPS come in even at the lower end of managements forecast of $4.83, Raytheon still only trades at a P/E of 10.4, which seems undervalued to me. Furthermore, we can afford the stock to trade at $45 and still achieve our 61% return. A $45 share price reflects a P/E range of 9.3-9.0, based on the company forecasts for 2011. None of this looks expensive but I will update again during the week to determine if any changes need to be made.

Exelon
Exelon reported fourth-quarter operating earnings of $0.96 per share, up 4% year over year, and full-year earnings of $4.06 per share, down 1.5% from 2009. Travis Miller of Mornignstar produced this insightful summary:

The key positive in Exelon’s quarterly disclosures was its hedging activity during the quarter at Exelon Generation, boosting management’s projections for 2011-13 gross margins. Exelon focused most of its hedging activity during the quarter in the Midwest, where it contracted an additional 3%-8% of its expected generation and raised its projected generation output for 2011-13. Its hedge positions in the Mid-Atlantic remained mostly the same during the quarter. The uptick in expected generation and a slight boost in hedged realized pricing for 2013 led management to raise the midpoint of its projected gross margin range by $50 million for 2011, $100 million for 2012, and $300 million for 2013. Our 2011 and 2012 gross margin estimates are in line with management’s new midpoints. We expect our 2013 gross margin estimate to be within management’s new range when we roll forward our long-term commodity price projections to 2014 and incorporate actual forward prices for 2013.
In the quarter, Exelon Generation benefited from a 28% drop in nuclear outage days and higher Pennsylvania power prices to earn $0.81 per share compared with $0.66 per share in the fourth quarter of 2009. However, a 1% drop in generation margins for the full year and higher depreciation and interest expenses offset the positives from fewer outage days and lower operating expenses, resulting in an 8.5% drop in full-year Generation earnings to $2.91 per share. We expected this drop and foresee continued earnings contraction at Generation at least through 2012.
ComEd ($0.13 per share) and PECO ($0.03 per share) both realized lower earnings in the fourth quarter from a drop in weather-normalized demand and higher operating expenses offset by slightly more favorable (colder) weather than during the fourth quarter of 2009. Adjusting for the $0.10 per share drop in earnings at PECO due to higher power prices that was offset by higher margins at Generation, PECO earnings rose by $0.01 per share in the fourth quarter. Both regulated units posted significantly higher full-year income after adjusting for the higher PECO power prices, helped by a big swing in weather-related usage. We expect the recent rate increase approved for PECO and expected for ComEd later this year should boost earnings at both utilities in 2011.

I continue to think that natural gas prices have upside rather than further downside potential and am confident that Exelon will benefit as a result. Regardless, it’s ability to produce low cost electricity whilst at the same time emitting minimal greenhouse gas emissions is enviable and should mitigate the effect of volatile power prices. There is still the prospect of Exelon making acquisitions which may hinder growth in the short term but encouragingly for investors in my view, Exelon has walked away from potential acquisitions over the few years that exceeded the price they were willing to pay. It is refreshing to some across management which doesn’t succumb to the “growth at all” cost syndrome. Looking at average analyst expectations for 2011, Exelon trades at an attractive P/E of 10.8. I am confident Exelon can achieve this target and therefore is an inexpensive call option to hold at this stage.

Transaction Update

SuperValu – Bought $7 April 11 Call

Full details of this transaction will be posted on the blog within the next couple of days

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

{ 0 comments }

29% Profit Pocketed in Transocean

by Brooks Wealth on January 25, 2011

Back on the 13th October, I bought Transocean (RIG) Call Options expiring in January 2013 at $6.75 per contract. Having watched the stock appreciate on the back of the rising price of oil, the subsequent move in the option price accelerated at a faster pace due to the added leverage facility options provide. Although, I could (and should) have taken profits a few days ago when my return could have exceeded 50%, I unfortunately delayed the decision unnecessarily and deservedly paid for my inaction. Instead, I sold my position yesterday with the option trading at $8.70 for a registered gain of 29% in just over 3 months. Whilst this is certainly nothing to be scoffed at, I am still kicking myself and wracking my brain for why exactly I didn’t act sooner when I had done the hard work of identifying the exit point. Such mistakes are all simply part of the learning curb involved with Investing, an education that never truly ends, which in my opinion adds to the mystique and my personal fascination with the markets. To put the profits into context, if I held Transocean to expiry in 2013, it would need to trade at just over $116 to recognize a 29% gain. Whilst that cannot be ruled out, it seems like a difficult hurdle and lies outside the base fair value I had previously assigned.

Elsewhere, Raytheon continues it’s recent move and having broken through the $50 barrier, offers us some added Margin of Safety in our investment. To recap, if the stock trades above $45 on the third Friday of January 2012, a 61% gain will be recognized. With the stock trading at $51.82 as of yesterdays close, that means we now have a 15% cushion for the stock to fall and still walk away with impressive profits. Furthermore, with our breakeven at $43.10, the stock could fall as much as 20% without us losing any of our investment. However, this week could see some further action in the stock price one way or another as Raytheon announces it’s quarterly results on Thursday 27th, along with rival Lockheed Martin. Fellow competitors Boeing and General Dynamics report a day earlier on the 26th. Matt Jarzemsky summarizes what to expect from Raytheon on the Dow Jones Newswire:

“Wall Street Expectations: Analysts were expecting a profit of $1.16 a share and$7.06 billion in revenue. The prior year, the company reported earnings of $ 1.30 a share and revenue of $6.67 billion.

Key Issues: The Surface Launched Advanced Medium Range Air-to-Air Missile it was developing for the army was among the procurement cuts in the new budget plan. Raytheon’s agreement last year to buy Applied Signal Technology Inc. ( APSG) for$490 million underscored defense contractors’ push into cyber security, a segment seen as relatively immune to budget cuts.”

Apart from that, the rest of the portfolio continues to hold up well. The Exelon call option moved into the money recently and at one stage was showing gains of as much as 19%. Whilst that has been trimmed to 4% as of yesterdays close, Exelon continues to look cheap by my valuations and with an attractive dividend coupled with an overbought market, investors will be more inclined to favor larger, dividend yielding stocks until such time as the performance disparity between large and small cap stocks narrows. This thesis can similarly be applied to our Health Care holding, Novartis. Trading at $57.50, I still need Novartis to advance a further 4% by the 3rd week in April to recognize a gain of 60%. My breakeven on the investment remains at $56.25, providing a small margin of safety. Like Exelon though, the stock does not look fundamentally expensive and with such strong history of cash flow and an appealing dividend, investors should take note.

As for the markets themselves, I admit to being rather cautious right now of the recent moves. Both the Nasdaq and S&P500 both look heavily overbought, both on the weekly and daily indicators I monitor. Interestingly, the Dow Jones looks less overbought than the other two indices, which further leads me to believe the large cap blue chips could be in line for a period of out-performance, relative to their smaller counterparts. Since December, I have been trimming the portfolio, selling positions in both Spectra Energy and Carters for tidy profits and now doing the same with Transocean. Whilst I don’t think the market is set to collapse or anything like that, as a largely contrarian investor, I do believe we are long overdue a correction. The technical indicators I follow care suggesting that time is now upon us. It is down to this reason I have held off entering into any Put Spreads so far in January. With the market in such overbought territory, the only smart investments right now (if any) are undervalued, dividend yielding stocks in my view. With that not being available to me in the options segment of my portfolio, I am content to wait before further deploying my cash at a more opportune time.

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace

{ 0 comments }

A Very Merry Christmas Indeed for the Portfolio

January 8, 2011

Another year down but more importantly, another intriguing and exciting year ahead of us in the markets. The action in the markets over the past month or so certainly added to the festive cheer and while I certainly am not complaining, the contrarian in me is beginning to believe this rally is looking particularly overbought. [...]

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
Read the full article →

Raytheon A Worry, Novartis Pops

December 17, 2010

When I included my put spread investment overview on Raytheon a few weeks, I highlighted some key technical price areas that warranted further attention. One of the key things I looked for in Raytheon was that it would at least hold above it’s 100 day Moving Average and continue it’s recent uptrend. The bad news….it [...]

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
Read the full article →

2 Undervalued Companies from Morningstar

December 14, 2010

Last week marked “Investors Ideas” week at Morningstar and Stock Investor editor Paul Larson, shared some insights into stocks he likes right now. In the first video, Paul discusses one of the most recent additions to his portfolio, Zimmer Holdings. The wide moat as a result of it’s intellectual property and in particular the switching [...]

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
Read the full article →

Raytheon Put Spread Investment Overview: Part 2

December 8, 2010

Following on from our previous post on Raytheon, where we provided an initial overview of the business itself, today I want to focus on the valuation process involved before deciding on whether or not to buy. I also want to talk a little on technical indicators, which although sometimes ignored by value investors, need to [...]

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
Read the full article →

Free Webcast With Pat Dorsey of Morningstar

December 6, 2010

To mark the beginning of “Ideas Week” at Morningstar, today we are being treated to a free webcast from Morningstar’s Director of Equity Research, Pat Dorsey. Pat is the author of The Five Rules for Successful Stock Investing: Morningstar’s Guide to Building Wealth and Winning in the Market and The Little Book that Builds Wealth: The Knockout [...]

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
Read the full article →

Raytheon Put Spread Investment Overview: Part 1

December 5, 2010

Company Overview Raytheon is a major United States defense contractor with nearly $25 billion in annual sales that operates through six segments: integrated defense systems, intelligence and information, missile systems, network-centric systems, space and airborne systems, and technical services. Sales to the U.S. government account for more than 88% of the company’s total sales. Waltham, [...]

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
Read the full article →